Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophre...

por Turkoz, Ibrahim, Wong, Joshua, Chee, Benjamin, Siddiqui, Uzma, Knight, R. Karl, Richarz, Ute, Correll, Christoph U.
Publicado 2023

Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia

por Najarian, Dean, Turkoz, Ibrahim, Knight, R Karl, Galderisi, Silvana, Lamaison, Hector F, Zalitacz, Piotr, Aravind, Suresh, Richarz, Ute
Publicado 2023

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a...

por Giron‐Hernandez, Cesar, Han, Joong Hee, Alberio, Roberta, Singh, Arun, García-Portilla, Maria Paz, Pompili, Maurizio, Knight, R Karl, Richarz, Ute, Gopal, Srihari, Antunes, José
Publicado 2023